MLTX - CIK 0001821586
As of 2026-06-11, MoonLake Immunotherapeutics (MLTX) has a market capitalization of $1.31 B, making it the #2448 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-11 | $1.31 B |
| 2026-06-10 | $1.28 B |
| 2026-05-29 | $1.40 B |
| 2026-05-28 | $1.34 B |
| 2026-05-26 | $1.34 B |
| 2026-05-25 | $1.33 B |
| 2026-05-24 | $1.33 B |
| 2026-05-22 | $1.33 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-11, MoonLake Immunotherapeutics (MLTX) has a market capitalization of $1.31 B, making it the #2448 most valuable US-listed company.
MoonLake Immunotherapeutics is the #2448 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.